October 23, 2019
CUSP’s chairman discusses DOJ’s treatment of controlled-medication prescribers in the current climate. “Detailed medical records are the only affordable way for a provider to prove his innocence — or at least make the prosecutor think twice about proceeding with criminal charges.”
October 13, 2019
July 25, 2019
In recent years, the DEA has been increasing the number of raids on prescribers. CUSP’s chairman gives more insight into this rising problem.
July 14, 2019
Based on the assorted promotional claims of cannabidiol (CBD) product marketers, it appears that the truth about CBD’s benefits and risks depends on whom you ask and when.
FDA Must Change Course on Addiction Treatment Medications
April 25, 2019
CUSP’s chairman discusses the Trump Administration’s opioid policies, warning that, unless the Food and Drug Administration changes its course, no new forms of the gold-standard medication for opioid addiction will come to market before 2024.
February 25, 2019
Three interconnected crises are currently happening in America: substance abuse, mental illness, and mass incarceration. All three can be curtailed by providing inmates with treatment and support during incarceration.
December 20, 2018
Looking forward to the 2020 campaign cycle and beyond, the United States is facing three large national crises: substance abuse, mental illness, and mass incarceration. All of these can be addressed if we fulfill an obligation required of us not only by the Constitution, but also by compassion and common sense.
Ruling on Affordable Care Act ‘Deeply Flawed’
December 17, 2018
Michael Barnes discusses the judicial decision deeming the Affordable Care Act unconstitutional and the potential impacts on consumers and states.
Insurance Reforms Vital to U.S. Economy
September 12, 2018
CUSP’s chairman explains that U.S. workers are not benefiting from wage increases because higher health-insurance premiums, deductibles, and copays are driving up U.S. inflation. Congress must implement health insurance reforms to control costs and make sure U.S. consumers can actually get treatments and medications when they need them.